Medical Marijuana: Regulatory Structure Seeks to Balance Interests of Multiple Stakeholders

The nation’s most populous state has moved to implement revisions and improvements to its regulatory framework for the production, transport, and sale of medical marijuana. Last week, California Governor Jerry Brown signed 3 bills designed to overhaul the state’s role in the oversight of medical cannabis. The legislation has support ranging from the cannabis industry to police, and city and state administrators. The new regulations culminate several years of failed attempts by the state legislature to reconcile the conflicting concerns of law enforcement and the multibillion dollar marijuana industry.

California is 1 of 23 states to legalize cannabis for medical use. The state is also considering joining Alaska, Colorado, Oregon, and Washington in approving marijuana for recreational use. In his signing message, Governor Brown stated, “This new structure will make sure patients have access to medical marijuana, while ensuring a robust tracking system. This sends a clear and certain signal to our federal counterparts that California is implementing robust controls not only on paper, but in practice.” The medical and scientific communities continue to advocate for more and better clinical trials to evaluate cannabis as a therapeutic option for chronic pain and other conditions, citing the deleterious effect of the DEA’s monopoly on the research supply in impeding the conduct of research.

PAINWeek faculty member Michael Schatman, PhD, CPE, discusses Marijuana and Pain Medicine: The Present and the Future. Watch the interview here.

Just how effective is medical marijuana? Read an article here.

Read a news report about the new legislation here.

An additional news story may be found here.

 

 

Related Content